Cargando…
Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets
Despite advances in immunosuppressive drugs, long-term success of liver transplantation is still limited by the development of chronic liver allograft dysfunction. Although the exact pathogenesis of chronic liver allograft dysfunction remains to be established, there is strong evidence that chemokin...
Autores principales: | Liu, Bin, Li, Jing, Yan, Lu-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870628/ https://www.ncbi.nlm.nih.gov/pubmed/24382971 http://dx.doi.org/10.1155/2013/325318 |
Ejemplares similares
-
CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction
por: Li, Jing, et al.
Publicado: (2016) -
Expression of GSK-3β in renal allograft tissue and its significance in pathogenesis of chronic allograft dysfunction
por: Yan, Qiang, et al.
Publicado: (2012) -
Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction
por: Veraar, Cecilia, et al.
Publicado: (2021) -
The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain
por: Montague, Karli, et al.
Publicado: (2017) -
Activation of Humoral Immunity during the Pathogenesis of Experimental Chronic Lung Allograft Dysfunction
por: Reichert, Martin, et al.
Publicado: (2022)